OAM
ACAD icon

OP Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

OP Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,549
Closed -$124K – 765
2026
Q1 		$124K Sell
5,549
-16,151
-74% -$386K ﹤0.01% 749
2025
Q4 		$580K Buy
21,700
+15,278
+238% +$365K 0.01% 642
2025
Q3 		$137K Sell
6,422
-32,718
-84% -$774K ﹤0.01% 753
2025
Q2 		$844K Buy
+39,140
New +$728K 0.01% 626

Other funds holding ACAD

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

OP Asset Management's ACAD Position: Q2 2026 in Review

OP Asset Management sold out of Acadia Pharmaceuticals (ACAD) in Q2 2026, closing a stake of 5,549 shares — an estimated $124K sold.

OP Asset Management first reported a position in ACAD in Q2 2025 and held it in 4 quarters. The position peaked at $844K in Q2 2025. 82 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • OP Asset Management reported no remaining Acadia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • OP Asset Management sold 5,549 Acadia Pharmaceuticals shares in Q2 2026, an estimated $124K.
  • OP Asset Management first reported a position in Acadia Pharmaceuticals in Q2 2025 and held it in 4 quarters.
  • OP Asset Management's Acadia Pharmaceuticals position peaked at $844K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.